National Bank of Canada’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

National Bank of Canada’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-882,584	Closed	-$102M	–	2957
2023 Q3	$102M	Buy	882,584 +663,542	+303%	+$71.3M	0.16%	129
2023 Q2	$22.6M	Buy	219,042 +199,868	+1,042%	+$21.1M	0.04%	331
2023 Q1	$2.09M	Sell	19,174 -21,371	-53%	-$2.36M	0.01%	843
2022 Q4	$4.61M	Sell	40,545 -26,869	-40%	-$2.23M	0.01%	636
2022 Q3	$4.23M	Sell	67,414 -31,053	-32%	-$2.17M	0.02%	573
2022 Q2	$7.89M	Buy	98,467 +58,604	+147%	+$5.55M	0.04%	434
2022 Q1	$4.59M	Buy	39,863 +30,255	+315%	+$2.95M	0.01%	632
2021 Q4	$1.02M	Buy	+9,608	New	+$1.05M	﹤0.01%	1051

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

National Bank of Canada's HZNP Position: Q4 2023 in Review

National Bank of Canada sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 882,584 shares — an estimated $102M sold.

National Bank of Canada first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $102M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

National Bank of Canada reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
National Bank of Canada sold 882,584 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $102M.
National Bank of Canada first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
National Bank of Canada's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $102M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.